CRISPR/Cas9 technology was used to introduce a single point mutation, an A-to-T transition at position 1135, resulting in an arginine to tryptophan mutation at amino acid 579 (R579W) that corresponds to the most common Pitt-Hopkins Syndrome mutation in humans R580W. (J:254983)